Published in Nat Rev Urol on August 14, 2012
Comprehensive molecular characterization of urothelial bladder carcinoma. Nature (2014) 8.48
Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell (2014) 5.52
Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance. Nature (2014) 2.52
G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic. Cancer Res (2013) 1.41
KRT14 marks a subpopulation of bladder basal cells with pivotal role in regeneration and tumorigenesis. Nat Commun (2016) 0.96
Biomarkers for bladder cancer management: present and future. Am J Clin Exp Urol (2014) 0.95
The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN. Sci Rep (2016) 0.90
Bladder Cancer Molecular Taxonomy: Summary from a Consensus Meeting. Bladder Cancer (2016) 0.89
A modified method for isolation of bladder cancer stem cells from a MB49 murine cell line. BMC Urol (2013) 0.88
Modelling bladder cancer in mice: opportunities and challenges. Nat Rev Cancer (2015) 0.86
Nephrogenic adenoma of the urinary tract: clinical, histological, and immunohistochemical characteristics. Virchows Arch (2013) 0.83
Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors. Oncotarget (2015) 0.83
Stem cell applications for pathologies of the urinary bladder. World J Stem Cells (2015) 0.82
RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells. Cell Death Dis (2015) 0.81
Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis. Oncotarget (2016) 0.81
Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute Forum. Urol Oncol (2014) 0.80
Sox4 Expression Confers Bladder Cancer Stem Cell Properties and Predicts for Poor Patient Outcome. Int J Biol Sci (2015) 0.80
Anatomy and Physiology of the Urinary Tract: Relation to Host Defense and Microbial Infection. Microbiol Spectr (2015) 0.79
Role of STAT3 pathway in genitourinary tumors. Future Sci OA (2015) 0.79
Role of isoenzyme M2 of pyruvate kinase in urothelial tumorigenesis. Oncotarget (2016) 0.78
In Vitro Evaluation of Spider Silk Meshes as a Potential Biomaterial for Bladder Reconstruction. PLoS One (2015) 0.77
The Combination of Three Natural Compounds Effectively Prevented Lung Carcinogenesis by Optimal Wound Healing. PLoS One (2015) 0.77
Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives. Int J Mol Sci (2015) 0.75
The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors. Bladder Cancer (2016) 0.75
Update on The Cancer Genome Atlas Project on Muscle-invasive Bladder Cancer. Eur Urol Focus (2015) 0.75
Positive association of collagen type I with non-muscle invasive bladder cancer progression. Oncotarget (2016) 0.75
Altered expression of CKs 14/20 is an early event in a rat model of multistep bladder carcinogenesis. Int J Exp Pathol (2015) 0.75
Increased bladder permeability in interstitial cystitis/painful bladder syndrome. Transl Androl Urol (2015) 0.75
Inhibition of STAT3 with the generation 2.5 antisense oligonucleotide, AZD9150, decreases neuroblastoma tumorigenicity and increases chemosensitivity. Clin Cancer Res (2016) 0.75
Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior. Sci Rep (2017) 0.75
Urothelial Generation and Regeneration in Development, Injury, and Cancer. Dev Dyn (2017) 0.75
A modified method by differential adhesion for enrichment of bladder cancer stem cells. Int Braz J Urol (2016) 0.75
A novel hedgehog inhibitor iG2 suppresses tumorigenesis by impairing self-renewal in human bladder cancer. Cancer Med (2016) 0.75
SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer. Stem Cell Reports (2017) 0.75
Toward personalized management in bladder cancer: the promise of novel molecular taxonomy. Virchows Arch (2017) 0.75
In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival. Virchows Arch (2017) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
Identification of human brain tumour initiating cells. Nature (2004) 38.87
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63
Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell (2003) 20.16
Generation of a functional mammary gland from a single stem cell. Nature (2006) 18.30
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet (2008) 17.67
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med (1996) 17.51
Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res (2006) 17.42
Stat3 as an oncogene. Cell (1999) 17.39
Purification and characterization of mouse hematopoietic stem cells. Science (1988) 15.99
Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature (2003) 14.35
Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A (2007) 13.58
A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature (2003) 12.81
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A (2007) 11.94
Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature (2009) 10.31
Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell (2005) 9.84
Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev (1998) 8.51
Stem cells: units of development, units of regeneration, and units in evolution. Cell (2000) 7.36
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet (2011) 5.73
Plasticity of adult stem cells. Cell (2004) 5.13
Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol (2006) 5.10
Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer (2005) 4.80
Stat proteins and oncogenesis. J Clin Invest (2002) 4.79
Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics (2006) 4.57
Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A (1992) 4.28
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A (2012) 4.20
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci U S A (2009) 3.87
Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet (2002) 3.82
Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res (2004) 3.76
Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest (2004) 3.70
Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell (2011) 3.55
The therapeutic promise of the cancer stem cell concept. J Clin Invest (2010) 3.26
Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature (2011) 3.15
Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc Natl Acad Sci U S A (1991) 3.14
Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer. Clin Chem (2007) 3.05
Epithelial stem cells in vivo. J Cell Sci Suppl (1988) 2.99
Inactivation of p53 and Pten promotes invasive bladder cancer. Genes Dev (2009) 2.99
A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment. Lancet Oncol (2011) 2.89
Focus on bladder cancer. Cancer Cell (2004) 2.59
Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors. Am J Pathol (2001) 2.55
Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res (2005) 2.29
Oligopotent stem cells are distributed throughout the mammalian ocular surface. Nature (2008) 2.24
Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium. Urol Oncol (2010) 2.16
Fluorescence-activated cell sorting. Sci Am (1976) 2.12
Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin Cancer Res (2003) 1.90
Loss of p63 expression is associated with tumor progression in bladder cancer. Am J Pathol (2002) 1.88
Epidermal stem cells: an update. Curr Opin Genet Dev (2006) 1.87
Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma. Proc Natl Acad Sci U S A (2012) 1.86
Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Cancer Epidemiol Biomarkers Prev (2010) 1.85
Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst (1992) 1.81
p63 regulates commitment to the prostate cell lineage. Proc Natl Acad Sci U S A (2005) 1.80
Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles. Eur Urol (2009) 1.79
The uroepithelium: not just a passive barrier. Traffic (2004) 1.75
Cell biology and physiology of the uroepithelium. Am J Physiol Renal Physiol (2009) 1.69
Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Histopathology (2004) 1.67
The human urothelium consists of multiple clonal units, each maintained by a stem cell. J Pathol (2011) 1.62
Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proc Natl Acad Sci U S A (2012) 1.60
Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells. Int J Cancer (2011) 1.58
Label-retaining cells of the bladder: candidate urothelial stem cells. Am J Physiol Renal Physiol (2008) 1.57
PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors. Cancer Res (2006) 1.57
Long-term outcome related to epidermal growth factor receptor status in bladder cancer. J Urol (1995) 1.49
Bladder permeability barrier: recovery from selective injury of surface epithelial cells. Am J Physiol Renal Physiol (2002) 1.44
Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Natl Cancer Inst (1993) 1.42
Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression. Am J Pathol (2011) 1.39
An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer. Cancer Res (2011) 1.37
Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. Stem Cells (2009) 1.30
Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme. J Cell Sci (2004) 1.29
Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer. Cancer Res (2012) 1.25
Cancer stem cells in bladder cancer: a revisited and evolving concept. Curr Opin Urol (2010) 1.23
Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells. Cancer Invest (2008) 1.23
p63 expression defines a lethal subset of muscle-invasive bladder cancers. PLoS One (2012) 1.22
The liberation of embryonic stem cells. PLoS Genet (2011) 1.20
Label retaining and stem cell marker expression in the developing rat urinary bladder. Urology (2011) 1.19
Identification of side population cells from bladder cancer cells by DyeCycle Violet staining. Cancer Biol Ther (2008) 1.17
Autocrine regulation of human urothelial cell proliferation and migration during regenerative responses in vitro. Exp Cell Res (2005) 1.13
Urothelial carcinoma of the bladder: definition, treatment and future efforts. Nat Rev Urol (2011) 1.11
Subpopulations of stem-like cells in side population cells from the human bladder transitional cell cancer cell line T24. J Int Med Res (2009) 1.01
Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer. Cancer Lett (2012) 1.00
Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer. Virchows Arch (2010) 0.99
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy. Lab Invest (2008) 0.96
Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas. Hum Pathol (1992) 0.96
Urothelial injuries and the early wound healing response: tight junctions and urothelial cytodifferentiation. Histochem Cell Biol (2005) 0.95
Growth factors in bladder wound healing. J Urol (1997) 0.95
Effects of PPAR agonists on proliferation and differentiation in human urothelium. Exp Toxicol Pathol (2008) 0.92
PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro. J Cell Physiol (2002) 0.91
Cystitis glandularis and adenocarcinoma of the bladder. J Urol (1971) 0.88
Stem-like cells in bladder cancer cell lines with differential sensitivity to cisplatin. Anticancer Res (2012) 0.86
Characterization of distinct functions for growth factors in murine transitional epithelial cells in primary organotypic culture. Exp Cell Res (1994) 0.85
Peroxisome proliferator-activated receptor gamma expression in urothelial carcinomas of the bladder: association with differentiation, proliferation and clinical outcome. Eur J Surg Oncol (2008) 0.84
Gene expression: Oestrogen receptor hijacked. Nature (2003) 0.83
Cellular heterogeneity in normal and neoplastic human urothelium: a study using murine monoclonal antibodies. Br J Cancer (1987) 0.81
Reorganisation of the urothelial luminal plasma membrane in the cyclophosphamide treated rats. Pflugers Arch (1996) 0.79
Squamous cell metaplasia of the bladder urothelium. A retrospective study of 36 patients. APMIS (1992) 0.78
Growth, differentiation and senescence of normal human urothelium in an organ-like culture. Eur Urol (2004) 0.76
DNA replication in experimental rat bladder tumours: immunohistochemical detection of bromodeoxyuridine labelled nuclei. Scand J Urol Nephrol Suppl (1989) 0.76
Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med (2004) 3.96
Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. J Dermatol Sci (2007) 1.40
Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer. Cancer Res (2012) 1.25
Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation. Cancer Res (2005) 1.24